Please login to the form below

Not currently logged in
Email:
Password:

Egypt

This page shows the latest Egypt news and features for those working in and with pharma, biotech and healthcare.

Sandoz to acquire GSK’s cephalosporin antibiotic brands for up to $500m

Sandoz to acquire GSK’s cephalosporin antibiotic brands for up to $500m

Pakistan, Egypt, Japan (to certain of the brands) and China.

Latest news

More from news
Approximately 1 fully matching, plus 15 partially matching documents found.

Latest Intelligence

  • Safe from harm? Safe from harm?

    Across the world, attitudes towards healthcare decision-making vary substantially. Peru (75%), Bolivia (75%), Egypt (71%) and Chile (66%) are the countries where physicians are most likely to make treatment decisions. ... Pharmacists are used to varying

  • Five myths about emerging markets Five myths about emerging markets

    Gilead's 90% discount to Egypt on hepatitis C treatment in return for very high volume, for example.

  • The MISTs of time - new emerging markets The MISTs of time - new emerging markets

    Booz notes: “Africa does not yet play a signi cant role in pharmaceutical sales, since South Africa, Egypt, Algeria, and Nigeria are the only markets in the region where the volume

  • Interview: Cesar Rodriguez, Janssen Interview: Cesar Rodriguez, Janssen

    The patients are in need of good medicines and solutions and answers to their questions – they're the same in Egypt and Romania and Spain and the UK.”. ... You can have access to the same information that Spain, the UK and Germany are getting whether

  • Interview: Giovanni Recordati Interview: Giovanni Recordati

    It is also considering the Middle East and Northern Africa. “Egypt is a big market. ... We have already made some investment there. And though there is some political tumult at present, in the medium- to longer-term, Egypt could be important for growth,

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

  • Janssen’s UK head moves to China Janssen’s UK head moves to China

    The move marks another step in a well-travelled career for Rodriguez, which includes spells in Spain, Romania and, during the Arab Spring, Egypt.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
M3 (EU)

M3 is the world’s largest network of verified doctors with over 6 million members across key markets; our closed and...

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...